Research
Our research focuses on the role of oxidative stress,
inflammation and lipoproteins modification in atherosclerosis and related
metabolic disorder syndromes.
We are also interested in clinical
laboratory new method development and validation studies.
The goal of our
current research is to outline the pathways responsible for the regulation of
plasma lipoproteins and factors which are associated with increased risk for
developing numerous metabolic disorders such as obesity, diabetes and
cardiovascular diseases. Diet and life style, like exercise and sedentary life
greatly impact lipoprotein metabolism and contribute to cardiovascular risk
which is modulated by a group of inflammatory and oxidative stress markers.
We are also interested in the role of platelets and blood thrombosis
factors in atherosclerosis.
Our lab also engages in development and
validation of methods of potential diagnostic application.
Cell culture,
animal models especially mouse lacking LDL receptors, dietary supplementation,
molecular biology and chromatographic techniques are used in our lab.
Technical Expertise
Our Current Technical expertise includes but not limited to the
following
Animal models:
- Rabbits for atherosclerosis, and hemodynamic studies.
- Extensive experience with mice models for
various diets, drugs and exercise experiments
- Good experience in cell culture and molecular biology.
Instrumentation:
- Great working experience with a variety of instruments and
techniques.
Software:
- Experince in a wide range of softwares
Center for Population Health
Core Laboratory
Garelnabi Research Group is also the Core Lab for the Center for the Health Population.
The laboratory
core provides analysis of nutrients, biomarkers and clinical Laboratory measurements.
Laboratory,
located at the new UMass
Lowell's Emerging Technologies and Innovation Center (ETIC).
Services include
- Samples Collections, Processing, cataloging and storage.
- Perform Basic and specialized Clinical Laboratory Analysis
- Determining effect of any dietary intake on metabolic responses.
- Investigating environmental factors on diseases.
- Perform animal models microscopic and surgical procedures
- Toxicity studies
Metabolic Biomarkers
- Lipids & Lipids Metabolites
- Vitamins
- Inflammatory markers
- Nutrients of interest
- Oxidative stress mechanisms studies
Clinical Chemistry Methods
Method verifications and Validation Studies
The Core Lab can also perform new and existing method verifications and validations studies for 510K submission.
- Methods validations
- Point of care testing instruments validation
Quality
Assurances
Core Lab follow GLP and specific available QA methods on analytes of
interest.
Follow
commercial manufacturer QA regimen.
The
Clinical & Laboratory Standards Institute (CLSI) approved guidelines as it
apply.
Team
Undergraduate students
Rhea Cabrera
Andrew Carvalho
Eden
Hok
Students completed undergraduate senior research projects:
The following undergraduate students have completed research training/projects in Garelnabi Research Lab:
- Mindasari Daniar
- Tyler Sullivan
- Sryesross Chhim
- Andrew E Carvalho
- Anthony Rodrigues
- Eden Hok
- Eric Bresnahan
- John Mensah
- Johnson Seng-Hy Lor
- Kassandre Danger
- Kim Sot
- Megan Rebello
- Michelle Ntori
- Nancy Sok
- Naseeha B Jamil
- Priscilla Stephens
- Rhea Mae Cabrera
- Romesa Hannan
- Samantha Zdanowicz
- Shannon Dizer
- Sung Chul Ho
- Thavaleak Prum
- Thuy Trang T Tran
- Yanick Dadaille
Anupriya Singh MS (spring 2011)
Rsearch Group photo 2010
******************************************************************************************************************************************************************************************************************************************************
Graduated Lab Members
Halleh
Mahini
Doctorate of Philosophy in
Biomedical Engineering and Bitechnology, May
2015.
Education:
PhD Biomedical Engineering & Biotechnology, May 2015
MS Biomedical Engineering & Biotechnology 2011
University of Massachusetts Lowell
B.S. Biological Sciences, 2008
University
of Massachusetts Lowell
Halleh Mahini presenting her work at the American Heart Association meeting in Chicago 2013
*************************************************************************************************************************************************************************************************************
Current Master Students 2016- :
Aza Elshiekh Ibrahim
Ahmed Alkhadra
Nadia Alghamdi
Osama Ahmed
***********************************************************************************************************************************************************
Doctoral Students
Chinedu C. Ochin, MBBS, MS.,
EDUCATION
University of Massachusetts-Lowell
PhD Candidate (Biomedical Engineering and Biotechnology) (Anticipated) 2017/18
MS (Biomedical Engineering and Biotechnology) May 2014
Ebonyi State University-Nigeria MBBS (Medicine and Surgery) Sept 2006
**************************************************************************************************************************************************************************************************************
Awards and Recognitions
Undergraduate students who received
Robert Niclosi Research Awards:
- Andrew Carvalho 2012
- Shannon Dizer 2013
- Eric
Bresnahan 2014
- Samantha Zdanowicz 2015
Graduate
students who received graduate Research Awards:
- Kenton Lor
MS 2011
- Jun Jin MS 2012
- Dhuha Fawaz H Alsayrafi 2016
- Sryesross Chhim 2017
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Recently Published Images from the
Lab
Clin Biochem. 2013 Jan;46(1-2):12-9.
Fig. (2). Possible mechanism of Lp(a) in stroke. Shows a simplified schematic of the possible connection between Lp(a) and stroke. The
LPA gene gets expressed and then the Lp(a) protein, gets assembled with ApoA1 and apoB either inside cells or outside in the plasma. The
assembled Lp(a) circulates in the plasma and the small sized Lp(a) particles can bind certain Blood vessel proteins and clump together; Lp
(a) inhibits plasmin which mediated the prevention of blood clot formation. Cardiovasc Hematol Disord Drug Targets. 2017;17(1):64-72. |